Inhibition of Trypanosoma evansi Protein-Tyrosine Phosphatase by Myristic Acid Analogues Isolated from Khaya senegalensis and Tamarindus indica

References

• Desquesnes M, Holzmuller P, Lai DH, Dargantes A, Lun ZR, Jittaplapong S. Trypanosoma evansi and Surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts, and pathogenic effects. Biomed Res Int. 2013;2013:1–22. doi:10.1155/2013/194176
   Web of Science ®Google Scholar
• Fong IW. New and emerging parasitic zoonoses, in emerging zoonoses. Fong IW, Editor. Cham, Switzerland. Springer Int Publishing. 2017;211–239.
   Google Scholar
• Singla LD, Juya PD, Sharma NS. Immune responses to haemorrhagic septicaemia (HS) vaccination in Trypanosoma evansi infected buffalo-calves. Trop Anim Hlth Prod. 2010;42:589–595. doi:10.1007/s11250-009-9461-1
   Web of Science ®Google Scholar
• Sumba AL, Mihok S, Oyieke FA. Mechanical transmission of Trypanosoma evansi and T. congolense by Stomoxys niger and S. taeniatus in a laboratory mouse model. Med Vet Entomol. 1998;12:417–422. doi:10.1046/j.1365-2915.1998.00131.x9824826
   PubMed Web of Science ®Google Scholar
• Muhanguzi D, Picozzi K, Hattendorf J, et al. The burden and spatial distribution of bovine African trypanosomes in small holder crop-livestock production systems in Tororo District, south-eastern Uganda. Parasites Vectors. 2014. doi:10.1186/s13071-014-0603-6
   Web of Science ®Google Scholar
• Swallow BM. Impacts of Trypanosomiasis on African Agriculture. Programme Against African Trypanosomiasis (PAAT) Technical and Scientific Series 2. FAO; 2000.
   Google Scholar
• Holt HR, Selby R, Mumba C, Napier GB, Guitian J. Assessment of animal African trypanosomiasis (AAT) vulnerability in cattle-owning communities of sub-saharan Africa. Parasites Vectors. 2016;9:53–64. doi:10.1186/s13071-016-1336-526825496
   PubMed Web of Science ®Google Scholar
• Vanhollebeke B, Truc P, Poelvoorde P, et al. Human Trypanosoma evansi infection linked to a lack of apolipoprotein 1. New Engl J Med. 2006;355:2752–2756.17192540
   PubMed Web of Science ®Google Scholar
• Nok AJ, Nzelibe HC, Yako SK. Trypanosoma evansi sialidase: surface localization, properties and hydrolysis of ghost red blood cells and brain cells-implications in trypanosomiasis. Z Naturforsh. 2003;58:594–601. doi:10.1515/znc-2003-7-825
   Google Scholar
• Habila N, Inuwa HM, Aimola IA, Udeh MU, Haruna E. Pathogenic mechanisms of trypanosoma evansi infections. Res Vet Sci. 2012;93:13–17. doi:10.1016/j.rvsc.2011.08.01121940025
   PubMed Web of Science ®Google Scholar
• Delespaux V, De Koning HP. Drug and drug resistance in African trypanosomiasis. Drug Resist Update. 2007;67:30–50. doi:10.1016/j.drup.2007.02.004
   Web of Science ®Google Scholar
• Szoor B, Wilson J, Mcelhinney H, Tabernero H, Keith R, Matthews R. Protein-tyrosine phosphatase TbPTP1: a molecular switch controlling life cycle differentiation in trypanosomes. J Cell Biol. 2006;175:293–303. doi:10.1083/jcb.20060509017043136
   PubMed Web of Science ®Google Scholar
• Seemay C, Bryan CJ, Marilyn P, Tom A, Christoph G. The trypanosome brucei life cycle switch Tbtpt1 is structurally conserved and dephosphorylates the nucleolar protein NOPP44/46. J Bio Chem. 2010;285:22075–22081. doi:10.1074/jbc.M110.10886020444707
   PubMed Web of Science ®Google Scholar
• Bakalara N, Seyfang A, Davis C, Baltz T. Characterization of a life-cycle-stage-regulated membrane protein tyrosine phosphatase in Trypanosoma brucei Eur J Biochem. 1995;234:871–877. doi:10.1111/ejb.1995.234.issue-38575447
   PubMedGoogle Scholar
• Persons M, Ledbetter JA, Schieven GL, Nel AE, Kanner SB. Developmental regulation of pp44/46, tyrosine-phosphorylated proteins associated with tyrosine/serine kinase activity in Trypanosoma brucei. Mol Biochem Parasitol. 1993;63:69–78. doi:10.1016/0166-6851(94)90009-4
   Web of Science ®Google Scholar
• Galán-Caridad JM, Calabokis M, Uzcanga G, Aponte F, Bubis J. Identification of casein kinase 1, casein kinase 2, and cAMP dependent protein kinase-like activities in Trypanosoma evansi. Mem Inst Oswaldo Cruz. 2004;99:845–854. doi:10.1590/S0074-0276200400080001115761601
   PubMed Web of Science ®Google Scholar
• Bakalara N, Seyfang A, Baltz T, Davis C. Trypanosoma brucei and Trypanosoma cruzi: life cycle-regulated protein tyrosine phosphatase activity. Exp Parasitol. 1995;81:302–312. doi:10.1006/expr.1995.11217498427
   PubMed Web of Science ®Google Scholar
• Vassella E. Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J Cell Sci. 1997;110:2661–2671.9427384
   PubMed Web of Science ®Google Scholar
• Pollitt LC, MacGregor P, Matthews K, Reece SE. Malaria and trypanosome transmission: different parasites, same rules? Trends Parasitol. 2011;27:197–203. doi:10.1016/j.pt.2011.01.00421345732
   PubMed Web of Science ®Google Scholar
• Roditi I, Lehane MJ. Interactions between trypanosomes and tsetse flies. Cur Op Microbiol. 2008;11:345–351. doi:10.1016/j.mib.2008.06.006
   PubMed Web of Science ®Google Scholar
• Atawodi SE, Ameh DA, Ibrahim S, et al. Indigenous knowledge system for treatment of trypanosomiasis in Kaduna State of Nigeria. J Ethnopharmacol. 2002;79:279–282. doi:10.1016/S0378-8741(01)00351-811801393
   PubMed Web of Science ®Google Scholar
• Wurochekke AU, Nok AJ. In vitro anti trypanosomal activity of some medicinal plants used in the treatment of trypanosomosis in northern Nigeria. Afri J Biotech. 2004;3:481–483. doi:10.5897/AJB2004.000-2094
   Google Scholar
• Umar IA, Ibrahim MA, Fari NA, Isa S, Balogun DA. In-vitro and in-vivo anti-trypanosoma evansi activities of extracts from different parts of khaya senegalensis. J Cell Animal Bio. 2010;4:91–95.
   Google Scholar
• Dingwoke EJ, Nzelibe HC, Sallau AB, Suleiman A. Purification and characterization of protein-tyrosine phosphatase from Trypanosoma evansi. Int J Sc Res. 2015;4:2281–2288.
   Google Scholar
• Zhang X, Xing S, Wu X, Lin F, Fu X, Li W. Purification and characterization of protein-tyrosine phosphatase MEG1 and preparation of anti-PTP MEG1 antibody. Chem Res Chin Univ. 2010;26:591–595.
   Web of Science ®Google Scholar
• Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Ameri Chem Soci. 1934;56:658–666. doi:10.1021/ja01318a036
   Web of Science ®Google Scholar
• Mattews K, Eleanor MB, Fredrerick JD, et al. Developmental regulation and extracellular release of a VSG expression-site-associated gene product from tyrpanosoma brucei bloodstream forms. J Cell Sci. 2010;123:4301–4311. doi:10.1242/jcs.07507721098637
   PubMed Web of Science ®Google Scholar
• Tabernero L, Aricescu AR, Jones EY, Szedlacsek SE. Protein tyrosine phosphatases: structure-function relationships. FEBS J. 2008;275:867–882. doi:10.1111/ejb.2008.275.issue-518298793
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Wang Y, Dixon JE. Dissecting the catalytic mechanism of protein-tyrosine phosphatases. Proc Natl Acad Sci. 1994;91:1624–1627. doi:10.1073/pnas.91.5.16248127855
   PubMed Web of Science ®Google Scholar
• Andersen JN, Mortensen OH, Peters GH, et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol. 2001;21:7117–7136. doi:10.1128/MCB.21.21.7117-7136.200111585896
   PubMed Web of Science ®Google Scholar
• Mustelin T, Tautz L, Page R. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site. J Mol Biol. 2005;354:150–163. doi:10.1016/j.jmb.2005.09.04916226275
   PubMed Web of Science ®Google Scholar
• Ostman A, Frijhoff J, Sandin A, Bohmer F. Regulation of protein tyrosine phosphatases by reversible oxidation. J Biochem. 2011;150:345–356. doi:10.1093/jb/mvr10421856739
   PubMed Web of Science ®Google Scholar
• Kuban-Jankowska A, Tuszynski JA, Winter P, Gorska M, Knap N, Wozniak M. Activation of hydrogen peroxide to peroxytetradecanoic acid is responsible for potent inhibition of protein-tyrosine phosphatase CD45. PLoS One. 2012;7:543–554. doi:10.1371/journal.pone.0052495
   Web of Science ®Google Scholar
• Ross CA, Taylor AM. Trypanocidal activity of a myristic acid analog in axenic cultures of trypanosoma evansi. Parasitol Res. 1994;80:147–153. doi:10.1007/BF009337838202455
   PubMed Web of Science ®Google Scholar
• Doering TL, Raper J, Buxbaum LU, et al. An analog of myristic acid with selective toxicity for African trypanosomes. Science. 1991;252(5014):1851–1854. doi:10.1126/science.18295481829548
   PubMed Web of Science ®Google Scholar
• Doering TL, Lu T, Werbovetz KA, et al. Toxicity of myristic acid analogs towards African trypanosomes. Proc Natl Acad Sci. 1994;91:919735–919739.
   Web of Science ®Google Scholar
• Arnold C. The new danger of synthetic drugs. Lancet. 2013;382:15–16. doi:10.1016/S0140-6736(13)61512-323841151
   PubMed Web of Science ®Google Scholar
• Gurney SM, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26:53–78.26226970
   PubMedGoogle Scholar
• Haq I. Safety of medicinal plants. Pak J Med Res. 2004;43(4):203–210.
   Google Scholar
• Rafieian-Kopaie M. Medicinal plants for renal injury prevention. J Renal Inj Prev. 2013;2(2):63–65. doi:10.12861/jrip.2013.2125340130
   PubMedGoogle Scholar
• Karimi A, Majlesi M, Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 2015;4:27–30.28197471
   PubMedGoogle Scholar
• Crans DC, Simone CM. Nonreductive interaction of vanadate with an enzyme containing a thiol group in the active site: glycerol-3-phosphate dehydrogenase. Biochem. 1991;30:6734–6741. doi:10.1021/bi00241a0152065057
   PubMed Web of Science ®Google Scholar
• Stone RL, Dixon JE. Protein-tyrosine phosphatases. J Biol Chem. 1994;269:31323–31326.7989293
   PubMed Web of Science ®Google Scholar